UPDATE: Cantor Fitzgerald Lowers PT on Ventrus Biosciences on 4Q Earnings Report
UPDATE: Cantor Fitzgerald Reiterates Synergy Pharmaceuticals at Buy on Late Breaker Announcement
UPDATE: Cantor Fitzgerald Upgrades Intuitive Surgical to Buy on Attractive Risk/Reward Profile
UPDATE: Cantor Fitzgerald Raises PT on Priceline.com, Growth Stronger Than Expected